These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7575834)

  • 1. Reversible steroid-induced hypertrophic cardiomyopathy with left ventricular outflow tract obstruction in two newborns.
    Haney I; Lachance C; van Doesburg NH; Fouron JC
    Am J Perinatol; 1995 Jul; 12(4):271-4. PubMed ID: 7575834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transient hypertrophic cardiomyopathy due to dexamethasone therapy in a premature infant].
    Pokela ML
    Duodecim; 1995; 111(14):1310-3. PubMed ID: 9244681
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of beta-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review.
    Fritz KI; Bhat AM
    J Perinatol; 1998; 18(1):38-44. PubMed ID: 9527943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.
    Ohning BL; Fyfe DA; Riedel PA
    Am Heart J; 1993 Jan; 125(1):253-6. PubMed ID: 8417533
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemopericardium and cardiac tamponade as presenting findings of dexamethasone-induced hypertrophic cardiomyopathy complicated by transmural myocardial infarction.
    Lilien LD; Lilien RH; Setrakian S
    Pediatr Cardiol; 2003; 24(3):280-3. PubMed ID: 12632228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic intraventricular flow obstruction after very-low-dose dexamethasone (Minidex) in preterm infants: case presentation and review of the literature.
    Paech C; Wolf N; Thome UH; Knüpfer M
    J Perinatol; 2014 Mar; 34(3):244-6. PubMed ID: 24573211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.
    Brand PL; van Lingen RA; Brus F; Talsma MD; Elzenga NJ
    Acta Paediatr; 1993; 82(6-7):614-7. PubMed ID: 8339005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
    Dani C; Bertini G; Simone P; Rubaltelli FF
    Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia.
    Werner JC; Sicard RE; Hansen TW; Solomon E; Cowett RM; Oh W
    J Pediatr; 1992 Feb; 120(2 Pt 1):286-91. PubMed ID: 1735831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary myocardial hypertrophy in a very small premature infant treated with dexamethasone].
    Korsch E; Gillor A; Groneck P; Bläker F
    Monatsschr Kinderheilkd; 1993 Feb; 141(2):112-5. PubMed ID: 8459811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucocorticoid-induced hypertrophic cardiomyopathy in premature infants: apropos of 4 cases].
    Boeuf B; Maragnes P; Belzic I; Lacotte J; Bonte JB; Guillois B
    Arch Pediatr; 1997 Feb; 4(2):152-7. PubMed ID: 9097827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant.
    Kale Y; Aydemir O; Ceylan O; Bas AY; Demirel N
    Pediatr Neonatol; 2015 Aug; 56(4):268-70. PubMed ID: 23639746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac effects of dexamethasone in very low birth weight infants.
    Bensky AS; Kothadia JM; Covitz W
    Pediatrics; 1996 Jun; 97(6 Pt 1):818-21. PubMed ID: 8657520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocortisone induced hypertrophic cardiomyopathy.
    Vimala J; Prabhu A; Pavithran S; Kumar RN
    Int J Cardiol; 2011 Aug; 150(3):e94-5. PubMed ID: 20045574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy with outflow tract obstruction-a complication of dexamethasone treatment for subglottic stenosis.
    Balys R; Manoukian J; Zalai C
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):271-3. PubMed ID: 15656964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive drugs and hypertrophic cardiomyopathy.
    Brand PL; Brus F
    Lancet; 1995 Jun; 345(8965):1644. PubMed ID: 7540240
    [No Abstract]   [Full Text] [Related]  

  • 17. Disopyramide as a negative inotrope in obstructive cardiomyopathy in children.
    Duncan WJ; Tyrrell MJ; Bharadwaj BB
    Can J Cardiol; 1991 Mar; 7(2):81-6. PubMed ID: 2049687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants.
    Israel BA; Sherman FS; Guthrie RD
    Am J Perinatol; 1993 Jul; 10(4):307-10. PubMed ID: 8397569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of hypertrophic cardiomyopathy with right ventricular outflow obstruction manifested during three-year follow-up study].
    Satoh R; Okada T; Oimatsu H; Sawai K; Ogawa T; Tuchida A
    Kokyu To Junkan; 1990 Sep; 38(9):913-7. PubMed ID: 2236965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertrophic cardiomyopathy in a low-birth-weight newborn treated with dexamethasone].
    Villa Alcázar M; Pellicer Martínez A; Burgueros Valero M; Quero Jiménez J
    An Esp Pediatr; 1996 Apr; 44(4):393-4. PubMed ID: 8796947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.